-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Market Perform on Amgen, Lowers Price Target to $415

Benzinga·10/12/2026 17:37:30
Listen to the news
BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $450 to $415.